Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.
作者信息
Alhashmi Hani, Kandil Magdy, Alhejazi Ayman, Motabi Ibraheem, Sagheir Ahmed, Alzahrani Musa, Dada Reyad, Al-Mansour Mubarak
机构信息
Adult Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Oncology Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
出版信息
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):195-201. doi: 10.4103/sjmms.sjmms_96_19. Epub 2019 Aug 28.
Abstract
摘要
相似文献
1
Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.霍奇金淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):195-201. doi: 10.4103/sjmms.sjmms_96_19. Epub 2019 Aug 28.
2
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.
3
Follicular Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.滤泡性淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):214-218. doi: 10.4103/sjmms.sjmms_101_19. Epub 2019 Aug 28.
4
Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.边缘区淋巴瘤：沙特淋巴瘤组诊断、管理及随访临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):202-208. doi: 10.4103/sjmms.sjmms_97_19. Epub 2019 Aug 28.
5
Mantle Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.套细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):226-230. doi: 10.4103/sjmms.sjmms_105_19. Epub 2019 Aug 28.
6
Diffuse Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.弥漫性大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):209-213. doi: 10.4103/sjmms.sjmms_98_19. Epub 2019 Aug 28.
7
Natural Killer/T-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.自然杀伤细胞/ T细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理和随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):222-225. doi: 10.4103/sjmms.sjmms_104_19. Epub 2019 Aug 28.
8
Primary Central Nervous System Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性中枢神经系统淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):219-221. doi: 10.4103/sjmms.sjmms_103_19. Epub 2019 Aug 28.
9
Primary Mediastinal Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性纵隔大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):231-233. doi: 10.4103/sjmms.sjmms_106_19. Epub 2019 Aug 28.
10
Hepatitis C Virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma.沙特阿拉伯B细胞非霍奇金淋巴瘤患者的丙型肝炎病毒感染
Saudi Med J. 2000 Aug;21(8):755-8.
引用本文的文献
1
Primary hepatic Hodgkin's lymphoma: A case report.原发性肝霍奇金淋巴瘤：一例报告。
J Family Med Prim Care. 2022 Mar;11(3):1184-1187. doi: 10.4103/jfmpc.jfmpc_1116_21. Epub 2022 Mar 10.
2
Clinicopathologic features and therapy outcome in childhood Hodgkin's lymphoma: a report from tertiary care center in Saudi Arabia.儿童霍奇金淋巴瘤的临床病理特征和治疗结果：来自沙特阿拉伯三级护理中心的报告。
J Egypt Natl Canc Inst. 2021 Aug 16;33(1):21. doi: 10.1186/s43046-021-00078-0.
3
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.
本文引用的文献
1
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.本妥昔单抗维迪西妥单抗联合苯达莫司汀：复发或难治性霍奇金淋巴瘤的高效一线挽救治疗方案。
Blood. 2018 Jul 5;132(1):40-48. doi: 10.1182/blood-2017-11-815183. Epub 2018 Apr 27.
2
Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.本妥昔单抗维迪西妥单抗联合苯达莫司汀治疗复发或难治性霍奇金淋巴瘤的国际多中心单臂 1/2 期临床试验。
Lancet Oncol. 2018 Feb;19(2):257-266. doi: 10.1016/S1470-2045(17)30912-9. Epub 2017 Dec 21.
3
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.帕博利珠单抗治疗复发/难治性经典型霍奇金淋巴瘤的疗效和安全性II期研究。
J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25.
4
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.纳武利尤单抗用于自体干细胞移植和维布妥昔单抗均治疗失败后的经典型霍奇金淋巴瘤：一项多中心、多队列、单臂2期试验。
Lancet Oncol. 2016 Sep;17(9):1283-94. doi: 10.1016/S1470-2045(16)30167-X. Epub 2016 Jul 20.
5
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma.复发或难治性霍奇金淋巴瘤患者使用维布妥昔单抗的5年生存率和疗效持久性结果
Blood. 2016 Sep 22;128(12):1562-6. doi: 10.1182/blood-2016-02-699850. Epub 2016 Jul 18.
6
Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.苯达莫司汀联合吉西他滨和长春瑞滨作为自体造血干细胞移植前诱导化疗治疗复发或难治性霍奇金淋巴瘤的有效方案：一项多中心 II 期研究的最终结果。
J Clin Oncol. 2016 Sep 20;34(27):3293-9. doi: 10.1200/JCO.2016.66.4466. Epub 2016 Jul 5.
7
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma.吉西他滨、地塞米松和顺铂（GDP）是一种针对复发/难治性弥漫性大B细胞淋巴瘤和霍奇金淋巴瘤的有效且耐受性良好的挽救疗法。
Leuk Lymphoma. 2017 Feb;58(2):324-332. doi: 10.1080/10428194.2016.1193852. Epub 2016 Jun 27.
8
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.基于中期PET-CT扫描指导的晚期霍奇金淋巴瘤适应性治疗
N Engl J Med. 2016 Jun 23;374(25):2419-29. doi: 10.1056/NEJMoa1510093.
9
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.III 期至 IV 期国际预后评分≥3、高危霍奇金淋巴瘤：ABVD 方案 8 个周期与 BEACOPPescalated 方案加 BEACOPPbaseline 方案 4 个周期比较、EORTC 20012 组间试验的 III 期研究的初步结果。
J Clin Oncol. 2016 Jun 10;34(17):2028-36. doi: 10.1200/JCO.2015.64.5648. Epub 2016 Apr 25.
10
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.PET-CT 用于分期和早期反应：来自晚期霍奇金淋巴瘤适应性治疗研究的结果。
Blood. 2016 Mar 24;127(12):1531-8. doi: 10.1182/blood-2015-11-679407. Epub 2016 Jan 8.
Zotero 插件